Cohen is an experienced financial and operations executive with extensive global leadership experience in medtech. He will replace Anna Wasyl, who is moving into the new role of chief commercial partnerships and operations officer, working closely with Chief Commercial Officer Massimiliano Colella.
“As we continue to invest in bringing Versius to more customers around the world, I am pleased to be further strengthening our leadership team with Shlomi’s appointment,” CEO Supratim Bose said in a news release. “His deep knowledge of the medical devices industry and high-growth businesses is a perfect fit for us. Shlomi will be hugely valuable to the team as we continue our rapid global scale up. I would like to thank Anna for her time as CFO, and we look forward to continuing to work closely with her in her new role.”
Related: CMR leaders on the ‘massive advantage’ of Versius and growing robotic surgery penetration
Most recently, he was the chief financial and operations officer at Lumenis, where he was responsible for driving a significant increase in sales and profitability and doubling the equity valuation of the business. Prior to his time at Lumenis, Cohen was chief financial officer at Formula Systems.
“Versius is an extremely innovative tool and I’m very excited to be part of the team that will help to further accelerate CMR’s growth to help the Company to achieve its mission of transforming surgery for good. CMR is an exciting, highly regarded global business in the medical devices sector. The Company is operating in a very fast-growing sector of the MedTech market, so I look forward to helping the Company to maximize this opportunity,” Cohen said.
